Stock screenerAll disclosures →
EDGAR →
VIR
Conviction 55HealthcareScan · Mon, Aug 10, 2026VIR$8.89+0.74%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.99M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price8.89
Change+0.74%
Gap+0.57%
Rel volume4.50×
Avg volume1.88M
Avg $ vol17.03M
SMA 209.07
SMA 509.28
SMA 2008.15
Price vs 50-4.22%
Price vs 200+8.97%
MA stackmixed
50/200 cross—
Supertrenddown · 10.05
RSI (14)45
MACD hist-0.01
MACD cross—
Stoch %K / %D31 / 26
ADX (14)27
+DI / −DI11 / 20
RSI divergence—
MACD divergence—
ATR %+5.11%
ADR %4.63%
52w high11.09
52w low4.28
From 52w high-19.88%
Above 52w low+107.59%
New 52w highNo
SqueezeOn · 2d
Bollinger width13.53%
%B0.35
Donchian pos29.20%
Donchian high9.77
Donchian low8.52
AVWAP (52w high)9.47
vs AVWAP high-6.18%
AVWAP (52w low)8.05
vs AVWAP low+10.33%
OBV trendFlat
Chaikin MF (20)-0.22
Today vs 20d4.50×
Avg vol (14d)1.99M
Avg vol (20d)1.88M
Avg $ vol (20d)17.03M
Market cap1.5B
RS 3m (vs SPY)-10.55%
RS 6m (vs SPY)+13.34%
RS line new highNo
Trend template6/8
Technical rank51.7
1 week-0.17%
1 month-10.79%
3 months-2.58%
6 months+23.57%
1 year+104.25%
YTD+49.58%
P/E-3.43
P/B1.53
P/S21.93
P/FCF-3.79
EPS-3.16
Div yield—
ROE-44.58%
ROA-36.05%
Debt/Eq—
Current6.04
EV/EBITDA-2.62
Gross margin—
Net margin-638.87%
Rev growth-7.61%
EPS growth16.09%
Price target21.29
Target upside139.62%
Analyst ratingBuy
Institutional94.29%
Ent. value1.22B
Revenue240K
Net income80.08M
Gross profit—
Free cash flow-396.61M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out168.65M
Employees367
ListedFri, Oct 11, 2019
Free float95.89M
Float %68.7%
Short interest18.45M
Days to cover12.0d
Short volume55.4%
Squeeze score89 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.47 vs $0.83
Last surprise-43.4% miss
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank51.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.56
Support8.52
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VIR
No recent disclosed trades by Congress in VIR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VIR · 7 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Coughlin Timothy Director · Stock Option (Right to Buy) · 2026-06-09 | Grant | 16K | $0 | 2026-06-09 | 2026-06-10 |
Coughlin Timothy Director · Common Stock · 2026-06-09 | Grant | 8K | $0 | 2026-06-09 | 2026-06-10 |
Sabatini Brent SVP, Chief Accounting Officer · Common Stock · 2026-06-01 | Sell | 379 | $4K | 2026-06-01 | 2026-06-02 |
Napolitano Janet Director · Common Stock · 2026-06-01 | Sell | 3.2K | $30K | 2026-06-01 | 2026-06-02 |
Napolitano Janet Director · Common Stock · 2026-05-27 | Grant | 8K | $0 | 2026-05-27 | 2026-05-28 |
BISCHOFBERGER NORBERT W Director · Stock Option (Right to Buy) · 2026-05-27 | Grant | 16K | $0 | 2026-05-27 | 2026-05-28 |
MORE ROBERT J Director · Stock Option (Right to Buy) · 2026-05-27 | Grant | 16K | $0 | 2026-05-27 | 2026-05-28 |
MORE ROBERT J Director · Common Stock · 2026-05-27 | Grant | 8K | $0 | 2026-05-27 | 2026-05-28 |
Sigal Charles Elliott Director · Common Stock · 2026-05-27 | Grant | 8K | $0 | 2026-05-27 | 2026-05-28 |
BISCHOFBERGER NORBERT W Director · Common Stock · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-28 |
SEC filings
EDGAR filings in VIR · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.